| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0004 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |